Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 3154
  • Home
  • Print this page
  • Email this page


 
   Table of Contents      
LETTER TO THE EDITOR
Year : 2018  |  Volume : 66  |  Issue : 1  |  Page : 177-178

Comment on “Impact of expansion of telemedicine screening for retinopathy of prematurity in India”


Vitreo-Retina Department, Biratnagar Eye Hospital, Biratnagar, Nepal

Date of Web Publication28-Dec-2017

Correspondence Address:
Dr. T Lalit Agarwal
Vitreo-Retina Department, Biratnagar Eye Hospital, Atithi Marg 17, Biratnagar
Nepal
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_777_17

Rights and Permissions

How to cite this article:
Agarwal T L, Aditya K, Agrawal N, Joshi I. Comment on “Impact of expansion of telemedicine screening for retinopathy of prematurity in India”. Indian J Ophthalmol 2018;66:177-8

How to cite this URL:
Agarwal T L, Aditya K, Agrawal N, Joshi I. Comment on “Impact of expansion of telemedicine screening for retinopathy of prematurity in India”. Indian J Ophthalmol [serial online] 2018 [cited 2019 Sep 22];66:177-8. Available from: http://www.ijo.in/text.asp?2018/66/1/177/221817



Sir,

We would like to call your attention to the article titled, “Impact of expansion of telemedicine screening for retinopathy of prematurity (ROP) in India” recently published in Indian Journal of Ophthalmology.[1]

There has been an underestimation in the expected treatment-requiring ROP babies in several states of India in this study.[1]

The incidence of ROP from rural Karnataka's multicenter study (KIDROP) is 22.39% of survived high-risk babies for any stage ROP and 3.57% of survived high-risk babies for treatment-requiring ROP.[2] This study uses this data to calculate the incidence of treatment- requiring ROP in the ten states but has taken 3.57% of those with any stage ROP and not the survived high-risk babies requiring screening.

The result of this study shows that the total population in the ten study states is 681.5 million. The eligible babies for ROP screening annually are 467,664. The number of babies admitted to neonatal units is 188,561, of which 160,277 are likely to survive and require screening.[1] Based on the KIDROP data,[2] ROP would develop in 35,886 of these infants, and 5722 (and not 1281) babies would require the treatment annually. The fiscal quantum of “blind person-years” saved in these ten states will be far higher than USD 108.4 million annually, reported in this study.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Vinekar A, Mangalesh S, Jayadev C, Gilbert C, Dogra M, Shetty B, et al. Impact of expansion of telemedicine screening for retinopathy of prematurity in India. Indian J Ophthalmol 2017;65:390-5.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Vinekar A, Jayadev C, Mangalesh S, Shetty B, Vidyasagar D. Role of telemedicine in retinopathy of prematurity screening in rural outreach centers in India-A report of 20,214 imaging sessions in the KIDROP program. Semin Fetal Neonatal Med 2015;20:335-45.  Back to cited text no. 2
[PUBMED]    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed1224    
    Printed0    
    Emailed0    
    PDF Downloaded79    
    Comments [Add]    

Recommend this journal